Patents Assigned to Oncotheraphy Science, Inc.
  • Genes and polypeptides relating to prostate cancers
    Patent number: 8067153
    Abstract: The present application provides novel human gene ELOVL7 whose expression is markedly elevated in prostate cancers. The gene and polypeptide encoded by the gene can be used, for example, in the diagnosis of prostate cancers, as target molecules for developing drugs against the disease, and for attenuating cell growth of prostate cancer.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: November 29, 2011
    Assignee: Oncotheraphy Science, Inc.
    Inventors: Yusuke Nakamura, Hidewaki Nakagawa, Shuichi Nakatsuru
  • SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX
    Publication number: 20090215683
    Abstract: The present invention is based on the observation that the co-activation of CDCA1 and KNTC2, and their cognate interactions, play significant roles in lung-cancer progression and that methods of inhibiting the complex can be used to treat non-small-cell lung cancer.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 27, 2009
    Applicant: Oncotheraphy Science, Inc.
    Inventors: Yusuke Nakamura, Yataro Daigo, Shuichi Nakatsuru
  • Method for treating or preventing metastasis of colorectal cancers
    Publication number: 20060111314
    Abstract: Disclosed are methods of detecting metastasis of colorectal cancer using differentially expressed genes. Also disclosed are methods of identifying agents for treating colorectal cancer or preventing metastasis of colorectal cancer.
    Type: Application
    Filed: August 14, 2003
    Publication date: May 25, 2006
    Applicants: Oncotheraphy Science, Inc., The University of Tokyo
    Inventors: Yusuke Nakamura, Yoichi Furukawa